Across rheumatic diseases

Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid Patient-reported Outcome (PRO))

Ann Rheum DisPublished Cross-sectional study

Authors' conclusion

The Steroid PRO is a 15-item, valid and reliable scale for measuring the impact of glucocorticoid therapy in people with rheumatic diseases.

Study context

Population
Adults from the UK, USA, Australia and New Zealand taking GC for a rheumatic disease833 (88%) women
Participants
946 adults
Outcome
Scale structure and psychometric properties of the Steroid PRO
Methodological detailssurvey, psychometric validation, Rasch measurement model, exploratory factor analysis, test-retest (follow-up 3-5 days later)
  • Survey
  • Psychometric validation
  • Rasch measurement model
  • Exploratory factor analysis
  • Test-retest (follow-up 3-5 days later)

Main finding

As reported in the abstract

Items removed due to lack of fit to Rasch model

25

Intraclass correlation coefficient (total score), excellent test-retest reliability

0.809

Observational data: associations, not effects.

Original publication

Validation of a new glucocorticoid-specific Patient-Reported Outcome Questionnaire (the Steroid PRO). Ann Rheum Dis. Published 15 February 2024. doi:10.1136/ard-2023-224946

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.